150 related articles for article (PubMed ID: 29043431)
1.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
2. (18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study.
Fonager RF; Zacho HD; Langkilde NC; Petersen LJ
BMC Cancer; 2016 Jan; 16():10. PubMed ID: 26753880
[TBL] [Abstract][Full Text] [Related]
3. Bony lesion analysis in carcinoma prostate: methylene diphosphonate bone scan vs. Gallium-68 psma-11 pet/ct.
Ali H; Rashid Ul Amin S; Hai A; Nizar N
J Ayub Med Coll Abbottabad; 2023; 35(3):415-418. PubMed ID: 38404083
[TBL] [Abstract][Full Text] [Related]
4. Comparison of
Zhang Y; Chen Y; Huang Z; Zhang L; Wan Q; Lei L
Contrast Media Mol Imaging; 2018; 2018():8271313. PubMed ID: 30254551
[TBL] [Abstract][Full Text] [Related]
5. The potential advantages of
Wang D; Guo C; Xiao J
Quant Imaging Med Surg; 2024 May; 14(5):3393-3404. PubMed ID: 38720843
[TBL] [Abstract][Full Text] [Related]
6. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
Kolade OU; Brink A; Ayeni AO; More S; Holness J
Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative diagnostic performance of
Deng J; Yang J; Wang Y; Liu G; Chen Y
Front Oncol; 2024; 14():1364311. PubMed ID: 38585006
[TBL] [Abstract][Full Text] [Related]
8. The role of 18F-NaF PET/CT in metastatic bone disease.
Araz M; Aras G; Küçük ÖN
J Bone Oncol; 2015 Sep; 4(3):92-7. PubMed ID: 26587375
[TBL] [Abstract][Full Text] [Related]
9. Comparison of
Ueda CE; Duarte PS; de Castroneves LA; Coura-Filho GB; Sado HN; Sapienza MT; Hoff AO; Buchpiguel CA
Nucl Med Mol Imaging; 2020 Dec; 54(6):281-291. PubMed ID: 33281999
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of skull bone viability and effect of early surgical intervention in electrical contact burns using 18 F-Sodium Fluoride PET-CT imaging.
Kumar P; Arora P; Kumar R; Singh H; Parashar A; Mittal BR; Bhattacharya A
Nucl Med Commun; 2024 Jun; 45(6):536-540. PubMed ID: 38595178
[TBL] [Abstract][Full Text] [Related]
11. (11)C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study.
Strandberg S; Karlsson CT; Sundström T; Ögren M; Ögren M; Axelsson J; Riklund K
EJNMMI Res; 2014 Dec; 4(1):55. PubMed ID: 26116118
[TBL] [Abstract][Full Text] [Related]
12. Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer.
Thurtle D; Hsu RC; Chetan M; Lophatananon A; Hubbard R; Gnanapragasam VJ; Barrett T
Br J Cancer; 2016 Nov; 115(11):1285-1288. PubMed ID: 27802450
[TBL] [Abstract][Full Text] [Related]
13. Molecular radiotheragnostics in prostate cancer.
Du Y; Dizdarevic S
Clin Med (Lond); 2017 Oct; 17(5):458-461. PubMed ID: 28974599
[TBL] [Abstract][Full Text] [Related]
14. Progress in diagnosis of bone metastasis of prostate cancer.
Liu J; Dong Y; Xu D; Zhang C; Lan T; Chang D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 46(10):1147-1152. PubMed ID: 34911846
[TBL] [Abstract][Full Text] [Related]
15. Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer.
Fleury V; Ferrer L; Colombié M; Rusu D; Le Thiec M; Kraeber-Bodéré F; Campion L; Rousseau C
Oncotarget; 2018 Aug; 9(60):31744-31752. PubMed ID: 30167091
[TBL] [Abstract][Full Text] [Related]
16. Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Tombal B; Lecouvet F
Adv Urol; 2012; 2012():893193. PubMed ID: 22013439
[TBL] [Abstract][Full Text] [Related]
17. Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with
Meißner S; Janssen JC; Prasad V; Brenner W; Diederichs G; Hamm B; Hofheinz F; Makowski MR
EJNMMI Res; 2017 Oct; 7(1):85. PubMed ID: 29058157
[TBL] [Abstract][Full Text] [Related]
18. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.
Borofsky S; George AK; Gaur S; Bernardo M; Greer MD; Mertan FV; Taffel M; Moreno V; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Radiology; 2018 Jan; 286(1):186-195. PubMed ID: 29053402
[TBL] [Abstract][Full Text] [Related]
19. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
Verma S; Choyke PL; Eberhardt SC; Oto A; Tempany CM; Turkbey B; Rosenkrantz AB
Radiology; 2017 Nov; 285(2):343-356. PubMed ID: 29045233
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in Defining Oligometastatic Prostate Cancer: Implications for Clinical Trial Accrual and Community Practice Adoption of Metastasis-Directed Therapy Approaches.
Dorff TB; Kasparian S; Garg N; Liu S; Pal SK; Wong J; Dandapani S
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
